HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Home and personal care and foods division directors to lead the two businesses and create "improved alignment," the company announces Aug. 4. Keki Dadiseth becomes home and personal care director effective Jan. 1, 2001, responsible for the worldwide business, including Lever soap, Mentadent toothpaste and Unilever Prestige beauty care. Regional presidents will remain responsible for profitability in their respective regions and will report to either the HPC or foods divisions. Second quarter turnover grew 3% to $10.92 bil. and net profit rose 16% to $562 mil

You may also be interested in...


Second quarter sales will increase 4% before acquisitions and disposals, largely driven by home and personal care products businesses, Investor Relations Director Howard Green reports during conference call with analysts June 25. Including acquisitions and disposals, sales are projected to advance more than 15%. Second quarter 2000 sales were $10.92 bil. (1"The Rose Sheet" Aug. 7, 2000, In Brief). Worldwide Dove sales and strength of Suave in U.S. are contributors to growth, firm says. North American sales expected to rise 23% with 20% due to acquisitions and disposals

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts